As of now, there is no publicly available detailed information about Amgen’s specific use of GPT-5. However, Amgen, as a leading biotechnology company, has shown strong interest in leveraging advanced AI technologies to accelerate drug discovery, optimize clinical trials, and enhance data analysis. 

If Amgen were to use GPT-5, it might involve applications such as:

- **Biomedical literature analysis:** Using GPT-5’s natural language processing capabilities to extract insights from vast scientific papers and research articles.
- **Drug discovery:** Assisting researchers in generating hypotheses or identifying potential drug candidates through AI-driven predictions.
- **Clinical trial optimization:** Enhancing patient recruitment and protocol design using AI-generated synthetic data or predictive modeling.
- **Internal communications and documentation:** Automating and improving the quality of reports, summaries, and knowledge sharing.

For the most accurate and up-to-date information, you may want to check Amgen’s official announcements, press releases, or technology partnerships.

If you have a particular aspect of Amgen’s use of AI or GPT models you want to explore, feel free to specify!